Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281018
Chembl Id: CHEMBL5281018
Max Phase: Preclinical
Molecular Formula: C33H46N6O6S
Molecular Weight: 654.83
Associated Items:
ID: ALA5281018
Chembl Id: CHEMBL5281018
Max Phase: Preclinical
Molecular Formula: C33H46N6O6S
Molecular Weight: 654.83
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCOCC3)nc3[nH]cnc23)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C33H46N6O6S/c1-6-31(4)15-22(32(5)19(2)7-9-33(20(3)27(31)43)10-8-21(40)26(32)33)45-24(42)17-46-29-25-28(35-18-34-25)37-30(38-29)36-23(41)16-39-11-13-44-14-12-39/h6,18-20,22,26-27,43H,1,7-17H2,2-5H3,(H2,34,35,36,37,38,41)/t19-,20+,22-,26?,27+,31-,32+,33+/m1/s1
Standard InChI Key: ZUIDLNWNDKWJRW-RKPWQCSBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 654.83 | Molecular Weight (Monoisotopic): 654.3200 | AlogP: 3.62 | #Rotatable Bonds: 8 |
Polar Surface Area: 159.63 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.65 | CX Basic pKa: 4.72 | CX LogP: 3.32 | CX LogD: 3.32 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.17 | Np Likeness Score: 0.41 |
1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y.. (2023) Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives., 14 (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004] |
Source(1):